We are pleased to announce that our company has recently welcomed 3 new investors, that share our mission and values, to bring new treatments for unmet clinical needs. This will allow us to grow, meet important upcoming milestones for our R&D pipelines, and mature our technologies.
We are excited to have them on board, and we would like to express our gratitude to all our shareholders, employees, and partners for their continued support.
A world-class biotechnology company in marine pharmaceutical research and development that aims to discover treatments to respond to unmet clinical needs.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
